These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 33047206)
1. Risk of chemotherapy-related amenorrhoea (CRA) in premenopausal women undergoing chemotherapy for early stage breast cancer. Turnbull AK; Patel S; Martinez-Perez C; Rigg A; Oikonomidou O Breast Cancer Res Treat; 2021 Feb; 186(1):237-245. PubMed ID: 33047206 [TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced amenorrhea and the resumption of menstruation in premenopausal women with hormone receptor-positive early breast cancer. Koga C; Akiyoshi S; Ishida M; Nakamura Y; Ohno S; Tokunaga E Breast Cancer; 2017 Sep; 24(5):714-719. PubMed ID: 28243992 [TBL] [Abstract][Full Text] [Related]
3. Relationship between reproductive history, anthropometrics, lifestyle factors, and the likelihood of persistent chemotherapy-related amenorrhea in women with premenopausal breast cancer. Abusief ME; Missmer SA; Ginsburg ES; Weeks JC; Partridge AH Fertil Steril; 2012 Jan; 97(1):154-9. PubMed ID: 22192139 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-related amenorrhea in premenopausal women with breast cancer. Lee S; Kil WJ; Chun M; Jung YS; Kang SY; Kang SH; Oh YT Menopause; 2009; 16(1):98-103. PubMed ID: 18849877 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast Cancer. Kabirian R; Franzoi MA; Havas J; Coutant C; Tredan O; Levy C; Cottu P; Dhaini Mérimèche A; Guillermet S; Ferrero JM; Giacchetti S; Petit T; Dalenc F; Rouanet P; Everhard S; Martin AL; Pistilli B; Lambertini M; Vaz-Luis I; Di Meglio A JAMA Netw Open; 2023 Nov; 6(11):e2343910. PubMed ID: 37971739 [TBL] [Abstract][Full Text] [Related]
6. A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer. Anders C; Marcom PK; Peterson B; Gu L; Unruhe S; Welch R; Lyons P; Behera M; Copland S; Kimmick G; Shaw H; Snyder S; Antenos M; Woodruff T; Blackwell K Cancer Invest; 2008; 26(3):286-95. PubMed ID: 18317970 [TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Pagani O; O'Neill A; Castiglione M; Gelber RD; Goldhirsch A; Rudenstam CM; Lindtner J; Collins J; Crivellari D; Coates A; Cavalli F; Thürlimann B; Simoncini E; Fey M; Price K; Senn HJ Eur J Cancer; 1998 Apr; 34(5):632-40. PubMed ID: 9713266 [TBL] [Abstract][Full Text] [Related]
8. Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103. Ruddy KJ; O'Neill A; Miller KD; Schneider BP; Baker E; Sparano JA; Dang C; Northfelt DW; Sledge GW; Partridge AH Breast Cancer Res Treat; 2014 Apr; 144(3):591-7. PubMed ID: 24584876 [TBL] [Abstract][Full Text] [Related]
9. Profiles of lipids, blood pressure and weight changes among premenopausal Chinese breast cancer patients after adjuvant chemotherapy. Yeo W; Mo FKF; Pang E; Suen JJS; Koh J; Loong HHF; Yip CCH; Ng RYW; Yip CHW; Tang NLS; Liem GS BMC Womens Health; 2017 Jul; 17(1):55. PubMed ID: 28750616 [TBL] [Abstract][Full Text] [Related]
10. Determinants of recovery from amenorrhea in premenopausal breast cancer patients receiving adjuvant chemotherapy in the taxane era. Minisini AM; Menis J; Valent F; Andreetta C; Alessi B; Pascoletti G; Piga A; Fasola G; Puglisi F Anticancer Drugs; 2009 Jul; 20(6):503-7. PubMed ID: 19339872 [TBL] [Abstract][Full Text] [Related]
11. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Fornier MN; Modi S; Panageas KS; Norton L; Hudis C Cancer; 2005 Oct; 104(8):1575-9. PubMed ID: 16134178 [TBL] [Abstract][Full Text] [Related]
12. [Observation and clinical significance of adjuvant chemotherapy-induced amenorrhea in premenopausal breast cancer patients]. Li HP; Ma LW; Zhang SL; Jia TZ; Deng HJ; Zhang ZH; Liang L; Wang MP; Xiao Y; Cao BS; Chen S; Wang YF Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):848-51. PubMed ID: 17416008 [TBL] [Abstract][Full Text] [Related]
13. The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: data from the randomised SBG 2000-1 study. Rosendahl M; Ahlgren J; Andersen J; Bergh J; Blomquist C; Lidbrink E; Lindman H; Mouridsen H; Bjerre K; Andersson M Eur J Cancer; 2009 Dec; 45(18):3198-204. PubMed ID: 19818599 [TBL] [Abstract][Full Text] [Related]
14. Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial. Swain SM; Land SR; Ritter MW; Costantino JP; Cecchini RS; Mamounas EP; Wolmark N; Ganz PA Breast Cancer Res Treat; 2009 Jan; 113(2):315-20. PubMed ID: 18302020 [TBL] [Abstract][Full Text] [Related]
15. The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane. Tham YL; Sexton K; Weiss H; Elledge R; Friedman LC; Kramer R Am J Clin Oncol; 2007 Apr; 30(2):126-32. PubMed ID: 17414460 [TBL] [Abstract][Full Text] [Related]
16. Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study. Sukumvanich P; Case LD; Van Zee K; Singletary SE; Paskett ED; Petrek JA; Naftalis E; Naughton MJ Cancer; 2010 Jul; 116(13):3102-11. PubMed ID: 20564648 [TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles. Liem GS; Mo FK; Pang E; Suen JJ; Tang NL; Lee KM; Yip CH; Tam WH; Ng R; Koh J; Yip CC; Kong GW; Yeo W PLoS One; 2015; 10(10):e0140842. PubMed ID: 26485568 [TBL] [Abstract][Full Text] [Related]
18. Individualized Prediction of Menses Recovery After Chemotherapy for Early-stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials. Pistilli B; Mazouni C; Zingarello A; Faron M; Saghatchian M; Grynberg M; Spielmann M; Kerbrat P; Roché H; Lorgis V; Bachelot T; Campone M; Levy C; Gonçalves A; Lesur A; Veyret C; Vanlemmens L; Lemonnier J; Delaloge S Clin Breast Cancer; 2019 Feb; 19(1):63-70. PubMed ID: 30241966 [TBL] [Abstract][Full Text] [Related]
19. Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer. Munster PN; Moore AP; Ismail-Khan R; Cox CE; Lacevic M; Gross-King M; Xu P; Carter WB; Minton SE J Clin Oncol; 2012 Feb; 30(5):533-8. PubMed ID: 22231041 [TBL] [Abstract][Full Text] [Related]
20. The frequency and predictors of persistent amenorrhea in premenopausal women with colorectal cancer who received adjuvant chemotherapy. Sahin T; Dizdar O; Ozdemir N; Zengin N; Ates O; Oksuzoglu B; Sendur MAN; Bilgin B; Demir M; Bozbulut UB; Kilickap S; Yalcin S Anticancer Drugs; 2019 Mar; 30(3):289-294. PubMed ID: 30640791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]